Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

Evolution of the cardiac function during the follow-up of the anticancer immunotherapy inhibiting PD-1 Recruiting

2024-517403-36-00 Cancer 6 2018-04-09
Phase 1/2 dose escalation and cohort expansion study evaluating MCLA-158 (petosemtamab) as single agent or in combination in advanced solid … Recruiting

2024-513627-16-01 Colorectal cancer metastatic 7 2018-03-28
A modular multi-Basket trial to improve personalized medicine in cancer patients Recruiting

2024-514238-19-00 Subjects with advanced solid tumour 4 2018-03-28
Paediatric Hepatic International Tumour Trial Recruiting

2024-516110-38-00 Hepatoblastoma and Hepatocellular Carcinoma 5 2018-03-06
Pre-operative capecitabine, oxaliplatin, docetaxel and atezolizumab in gastric cancer (PANDA) Recruiting

2024-519075-26-00 Primary resectable, histologically confirmed gastric or 4 2018-02-27
Adjuvant immunotherapy after salvage surgery in head and neck squamous cell carcinoma: phase 2 trial evaluating the efficacy and the toxicit… Recruiting

2024-516810-39-00 Adjuvant therapy after salvage surgery of high risk rec 4 2018-02-13
Study to allow access to dabrafenib and/or trametinib for subjects that are benefiting from dabrafenib and/or trametinib treatment in a Nova… Recruiting

2023-509318-13-00 Multiple indications 6 2018-01-15
A multicenter trial where patients with CML stop medication a second time. Recruiting

2024-515409-25-00 Chronic myeloid leukemia 4 2018-01-11
LONG-TERM FOLLOW-UP STUDY OF EARLY STAGE BREAST CANCER PATIENTS INCLUDED IN GEICAM STUDIES Recruiting

2022-502706-33-00 Patients with invasive breast cancer in early stages 6 2018-01-10
FASTERCC Recruiting

2024-515413-18-00 Metastatic renal cell carcinoma (mRCC) 4 2017-12-22
Phase II Study of Nivolumab (Group 1) and Nivolumab plus Relatlimab (Group 2) in Patients with Locally Advanced/ Metastatic Squamous Cell Ca… Recruiting

2024-513637-20-00 Locally Advanced/Metastatic Squamous Cell Carcinoma of 4 2017-03-24
Nordic Pancreatic Cancer Trial (NORPACT) – 1 Recruiting

2024-517719-65-00 Resectable pancreatic head cancer 4 2017-02-01
A Study to Evaluate the Safety, Efficacy, Tolerability and Pharmacokinetics of Escalating Doses of Glofitamab (RO7082859) as a Single Agent … Recruiting

2023-505625-14-00 Relapsed/refractory B-cell non-Hodgkin’s lymphoma (r/r 7 2017-01-31
Neoadjuvant immune checkpoint inhibition and novel IO combinations in early-stage colon cancer - the NICHE trial Recruiting

2024-513314-35-00 Adenocarcinoma of the Colon or rectosigmoid (considered 4 2017-01-20
Substantially improving the cure rate of high-risk BRCA1-like breast cancer patients with personalized therapy (SUBITO) - an international r… Recruiting

2024-516196-32-00 breast cancer 5 2017-01-01
Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) Recruiting

2023-506987-15-00 Metastatic Castration-Resistant Prostate Cancer 9 2016-11-17
A phase II study to assess the efficacy of the anti-PD-L1 antibody atezolizumab (MPDL3280A) administered with stereotactic ablative radiothe… Recruiting

2024-515678-29-00 Patients with metastatic tumours (colorectal, non-small 4 2016-11-15
Evaluation of Lymphadenectomy and Chemotherapy TIP (paclitaxel, ifosfamide and cisplatin) on Inguinal Lymph Nodes in Squamous Cell Carcinoma… Recruiting

2024-512827-36-00 Penis carcinoma 4 2016-10-17
AcSé-ESMART: European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors Recruiting

2024-514791-40-00 pediatric cancer 9 2016-08-03
DRUP trial Recruiting

2023-509152-33-00 Advanced solid tumor 4 2016-07-25
Safety of Lanreotide 120 mg ATG in combination with Metformin in patients with progressive advanced Well-differentiated gastro-intestinal (G… Recruiting

2024-513200-34-00 advanced progressive gastro-intestinal or lung carcinoi 4 2016-04-19
Vaccination with autologous dendritic cells loaded with autologous tumour homogenate after curative resection for stage IV colorectal cancer… Recruiting

2024-516221-31-00 Stage IV colorectal cancer 4 2016-04-19
VICTORIA (hormone receptor postiVe endometrIal Carcinoma treated by dual mTORC1/mTORC2 Inhibitor and Anastrozole):A Multicentric, randomized… Recruiting

2024-516725-31-00 advanced and metastatic 9 2016-04-14
SIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependym… Recruiting

2024-512222-28-00 Newly diagnosed with an intracranial or spinal ependymo 10 2015-06-02